BiondVax, MonoSol team up on oral flu vaccine; Intercell fell due to poor sales of vax against Japanese encephalitis;

@AlisonBFierce: U. of Minnesota researchers call for a better flu vaccine, but say financial risk throws up roadblocks. More | Follow @AlisonBFierce

> Researchers will test four experimental HIV vaccines in a region in South Africa where one in 5 adults is infected with HIV. More

> New Australian research shows the national cervical cancer vaccination program is eliminating most cases of genital warts, a leading cause of the cancer. Story

> Despite a West Nile virus outbreak and deaths caused by the disease, the realization of a human vaccine seems distant. News

> Dutch researchers took a look at the plausibility of inhaled vaccines. Article

> Intercell stock fell after the company warned its only marketable product, a vaccine against Japanese encephalitis, hadn't sold as much as anticipated. Item

> Genticel announced positive data from its Phase I trial in women infected with high-risk HPV before appearance of cervical lesions. Release

> Novavax reported positive results from two Phase II trials of pandemic influenza vaccine. Release

> St. Louis University's Center for Vaccine Development is beginning a clinical trial to test different doses of a new pneumonia vaccine, PCV13 Prevnar, in older adults. Report

And Finally... BiondVax Pharmaceuticals and MonoSol Rx have teamed up on an oral flu vaccine. News

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

As a new coronavirus spreads, vaccine researchers have started work on candidates against the virus—and one could enter the clinic in a few months.

Merck's HPV vaccine Gardasil is delivering blockbuster sales as demand surges. But high demand has caused somewhat of a supply constraint.